Applied Industrial (AIT) COO Wagner Receives RSUs and SARs; Details of Vesting
Rhea-AI Filing Summary
Richard M. Wagner, Chief Accounting Officer of Applied Industrial Technologies, reported equity awards granted on 08/12/2025. He was granted 286 restricted stock units (RSUs) that vest four years from the grant date and are settled in shares of Applied common stock. He was also granted 1,705 stock-only stock appreciation rights (SARs) with an exercise/conversion reference price of $270.68; these SARs become exercisable in annual increments of 25% beginning 08/12/2026 and expire 08/12/2035. Following the reported transactions, the Form 4 shows beneficial ownership of 988 shares of common stock and 1,705 SARs (underlying 1,705 shares), all reported as direct holdings. The Form 4 was signed by Patricia A. Comai as POA for Mr. Wagner on 08/14/2025.
Positive
- Transparent disclosure of award types, quantities, vesting, exercise schedule, and prices in compliance with Section 16 reporting
- Long-term alignment: RSUs and SARs tie compensation to future share performance with multi-year vesting/exercisability
Negative
- No negative items within the filing itself; the Form 4 reports routine equity compensation rather than adverse events
Insights
TL;DR: Routine executive equity awards were granted; no cash transaction or immediate dilution reported.
The filing documents standard long-term compensation: 286 RSUs that will convert to shares after a four-year vesting period and 1,705 SARs priced at $270.68 with staggered exercisability. These are compensation instruments intended to align executive incentives with share performance over multi-year horizons. The Form 4 shows direct beneficial ownership figures post-grant but does not report any cash proceeds or secondary transactions. The disclosure is procedural and typical for named officers; it does not by itself indicate operational or financial performance changes.
TL;DR: Compensation disclosure follows Section 16 reporting norms; vesting and exercisability schedules are clearly stated.
The Form 4 transparently discloses the award types, vesting timeline for RSUs, and the SAR exercisability schedule (25% annual tranches beginning one year after grant). All reported holdings are direct. The form includes a POA signature, which is acceptable for timely filing. There is no indication of related-party transactions, departures, or amendments to prior disclosures within this filing.